Sorrento CEO, BioReference CEO And The Great Outdoors

Mad Money w/ Jim Cramer

CNBC

News, Investing, Business

4.3 • 4K Ratings

🗓️ 20 July 2020

⏱️ 47 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

As Sorrento Therapeutics gains FDA approval for phase two of their COVID-19 treatment, how should investors approach the stock? CEO Dr. Henry Ji checks in to discuss the company's latest developments against coronavirus after today's 20% gain. Then, BioReference Labs CEO Dr. Jon Cohen joins Cramer to talk about testing the NBA, major league soccer, and expanding testing throughout the U.S. as the pandemic continues. Plus, Cramer's revealing 4 stocks in the outdoor space that could be worth looking at.

Transcript

Click on a timestamp to play from that location

0:00.0	My mission is simple to make you money.
0:05.0	I'm here to level the playing field for all investors.
0:08.0	There's always a more work at Summer,
0:10.0	and I'm proudest to help you find it.
0:12.0	Man money starts now.
0:17.0	Hey, I'm Cramer.
0:19.0	Welcome to Man Money.
0:20.0	Welcome to Cramer, a good one big friends.
0:22.0	Just trying to make you a little money.
0:23.0	My job is not just to entertain you,
0:25.0	but to teach you so call me at 1-800-743.
0:27.0	See me see, and be nice, tweet me at Jim Cramer.
0:30.0	The market!
0:32.0	The market is in child!
0:37.0	It's childless and it's tempestuous demands.
0:40.0	It's lack of discipline.
0:41.0	It's disproportionate sense of euphoria!
0:46.0	And in disappointment.
0:52.0	And the child is creating monster swings
0:54.0	of major large capitalization stocks,
0:56.0	the lights of which I have never ever seen before, ever.
0:59.0	Just look at what happened today.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from CNBC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of CNBC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.